FI923498A - Foerfarande foer framstaellning av 3-deoximannosaminderivat - Google Patents

Foerfarande foer framstaellning av 3-deoximannosaminderivat Download PDF

Info

Publication number
FI923498A
FI923498A FI923498A FI923498A FI923498A FI 923498 A FI923498 A FI 923498A FI 923498 A FI923498 A FI 923498A FI 923498 A FI923498 A FI 923498A FI 923498 A FI923498 A FI 923498A
Authority
FI
Finland
Prior art keywords
deoximannosaminderivat
foerfarande foer
foer framstaellning
framstaellning
foerfarande
Prior art date
Application number
FI923498A
Other languages
English (en)
Other versions
FI923498A0 (fi
Inventor
Nicola Mongelli
Alberto Bargiotti
Nuccia Oneto
Cristina Geroni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI923498A0 publication Critical patent/FI923498A0/fi
Publication of FI923498A publication Critical patent/FI923498A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI923498A 1991-08-06 1992-08-03 Foerfarande foer framstaellning av 3-deoximannosaminderivat FI923498A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
FI923498A0 FI923498A0 (fi) 1992-08-03
FI923498A true FI923498A (fi) 1993-02-07

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923498A FI923498A (fi) 1991-08-06 1992-08-03 Foerfarande foer framstaellning av 3-deoximannosaminderivat

Country Status (16)

Country Link
US (1) US5332756A (fi)
EP (1) EP0527042A2 (fi)
JP (1) JPH05208988A (fi)
KR (1) KR930004325A (fi)
AU (1) AU646173B2 (fi)
CA (1) CA2075336A1 (fi)
FI (1) FI923498A (fi)
GB (1) GB9116896D0 (fi)
HU (1) HU213208B (fi)
IL (1) IL102500A (fi)
MX (1) MX9204395A (fi)
MY (1) MY108749A (fi)
NZ (1) NZ243627A (fi)
RU (1) RU2099333C1 (fi)
TW (1) TW248564B (fi)
ZA (1) ZA925871B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1757296A4 (en) * 2004-05-26 2010-09-01 Rare Sugar Production Technica METHOD FOR CONTROLLING THE PROLIFERATION OF TISSUE ENDHELICELLS AND INHIBITION OF LUMENING
US8148335B2 (en) * 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
KR20070060069A (ko) * 2004-06-23 2007-06-12 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 다당류 유도체 및 면역반응의 유도에서의 용도
US20090214439A1 (en) * 2006-03-15 2009-08-27 Trustees Of Tufts College Fluorinated Carbohydrates and Their Use in Tumor Visualization, Tissue Engineering, and Cancer Chemotherapy
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
JP5597130B2 (ja) * 2007-07-03 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド ポリシアル酸脱n−アセチラーゼの阻害剤及びその使用方法
CA2692417C (en) 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
CA2690440A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
RU2099333C1 (ru) 1997-12-20
CA2075336A1 (en) 1993-02-07
AU646173B2 (en) 1994-02-10
FI923498A0 (fi) 1992-08-03
EP0527042A3 (fi) 1994-01-05
MY108749A (en) 1996-11-30
HU9202329D0 (en) 1992-10-28
ZA925871B (en) 1993-04-28
EP0527042A2 (en) 1993-02-10
HU213208B (en) 1997-03-28
TW248564B (fi) 1995-06-01
JPH05208988A (ja) 1993-08-20
GB9116896D0 (en) 1991-09-18
MX9204395A (es) 1993-02-01
IL102500A0 (en) 1993-01-14
HUT62593A (en) 1993-05-28
IL102500A (en) 1996-01-19
KR930004325A (ko) 1993-03-22
NZ243627A (en) 1994-04-27
US5332756A (en) 1994-07-26
AU2037492A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
FI921369A (fi) Anvaendarfoerbindelse foer kontrollsystem av anlaeggningskomponenter
FI922273A (fi) Framstaellning av additionspolymerisationskatalysatorer
FI921599A (fi) Kodingsfoerfarande och -anordning foer foerutsaegning av roerelsekompensation
FI920875A (fi) Foerfarande foer avfaergning av avfallspapper
FI921828A (fi) Dehalogenisering av foereningar innehaollande organohalogener
FI921299A (fi) Laongspaltpress saerskilt foer avvattning av en fiberaemnesbana
FI921749A (fi) Tillverkning av tryckkaerl
FI921290A (fi) Skenlaeggningsmaskin foer kontrollerad nedsaenkning av en skena
FI921149A (fi) Reaktivering av hydroformyleringskatalysatorer
FI921202A (fi) Foerfarande foer instaellning av rasterpunktstorleken foer en offset-rotationstryckmaskin
FI920993A (fi) Foerfarande foer framstaellning av galliumfoereningar
FI921037A (fi) Vaermesensor av kompensationstyp
FI921721A (fi) Foerfarande foer isynnerhet foersnabbad aerobisk mikrobiologisk nedbrytning av biologiska aemnen
FI923498A (fi) Foerfarande foer framstaellning av 3-deoximannosaminderivat
FI921458A (fi) Hjaelpmedel foer svetsning av ytterst korrosionsbestaendiga austenitiska staol
FI88701B (fi) Foerfarande foer producering av vaeteperoxid
FI922381A (fi) Foerfarande foer framstaellning av amorfa provkroppar
FI914586A (fi) Foerfarande foer foerminskning av asklasten av en cellufabriks pannanlaeggning
FI921404A (fi) Foerfarande foer framstaellning av elektrolumisescens tunnfolie
FI921103A (fi) Foerfarande foer framstaellning av oxamid
FI922125A (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra
FI920422A (fi) Foerfarande foer ytfoerening av kiselhalvledarskivor
FI920926A (fi) Foerfarande foer foerbaettring av stabiliteten foer hoegalkaliska proteaser
FI922138A (fi) Anordning foer belysning av en hisskorgs innerrum
FI912871A (fi) Foerfarande foer boejning av glasskivor

Legal Events

Date Code Title Description
FD Application lapsed